Does the SARS-CoV-2 Spike in Vaccines Weaken DNA Damage Repair & Adaptive Immunity?

Does the SARS-CoV-2 Spike in Vaccines Weaken DNA Damage Repair & Adaptive Immunity?

Recently, scientists working out of Sweden probed the SARS-CoV-2 spike’s ability to damage DNA in SARS-CoV-2 infected hosts. A troubling prospect, the study authors focused on the lack of adaptive immunity associated with severe COVID-19 patients. Clinical microbiologist Hui Jiang working out of both Umeå University and The Wenner–Gren Institute, Stockholm University, as well as Ya-Fang Mei, the virologist lead at Umeå University, found in a laboratory study using in vitro cell lines that the SARS-CoV-2 spike protein “significantly inhibits DNA damage repair,” necessary for the adaptive immunity for recovering from severe cases of the illness. This occurs as the spike protein associated with the novel coronavirus “localizes in the nucleus and inhibits DNA damage repair by impeding key DNA repair protein BRCA1 and 53BP1 recruitment to the damage site.” The pair hypothesize: could they have discovered how COVID-19 impedes the infected patient’s adaptive immunity? More disturbingly, does this breakthrough point out that the possible side effects of full-length spike-based vaccines?

Both Hui Jiang and a Ya-Fang Mei sought to better understand the mechanism making SARS-CoV-2, the vi...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee